Chondroitin 4-sulfate?

CAS No. 24967-93-9

Chondroitin 4-sulfate?( —— )

Catalog No. M24138 CAS No. 24967-93-9

Chondroitin sulfate is an important structural component of cartilage and has been used as a dietary supplement for the treatment of joint discomfort.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 49 In Stock
50MG 72 In Stock
100MG 105 In Stock
200MG 156 In Stock
500MG 263 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Chondroitin 4-sulfate?
  • Note
    Research use only, not for human use.
  • Brief Description
    Chondroitin sulfate is an important structural component of cartilage and has been used as a dietary supplement for the treatment of joint discomfort.
  • Description
    Chondroitin sulfate is an important structural component of cartilage and has been used as a dietary supplement for the treatment of joint discomfort.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    24967-93-9
  • Formula Weight
    ——
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Propyl octanoate

    Propyl octanoate (Propyl n-Octanoate) is an industrial raw material commonly used in coatings, inks, lubricants and other fields.

  • 25-PYRIDINEDICARBOXY...

    25-Pyridinedicarboxylic Acid is used in the preparation of new derivatives as antiviral agents.

  • PACAP (1-38), human,...

    PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), and VIP release. PACAP 1-38 (10-8 M) inhibited gastrin secretion and stimulated somatostatin secretion and motility dose-dependently.